Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 14836 total
Clean Harbors reported Q3 results on October 28 against a backdrop where options traders had turned sharply more cautious than at any point in recent memory, even as sell-side targets climbed and the stock drifted…
CVX shed 1.6% Tuesday to $228.23, a slightly larger daily drop than most of its closest peers, though the stock is still up 1.1% on the week, roughly in line with the 1.2% median across the peer group. Among the names…
CLS delivered a sharp one-day reversal on October 27, climbing 12% to CAD 388.33 after its Q3 earnings release. That bounce follows a brutal run: the stock is still down 25% over the past month and down 8% on the week,…
Caterpillar has recovered $26 from Monday's close, ending Tuesday at $713, but tomorrow's Q3 results make that partial rebound almost beside the point. Short sellers have not been building positions into this print.…
Capitol Federal Financial reports after the close today with an activist shareholder on the register, short interest quietly rebuilding, and options traders making their most bullish bet in months. The most newsworthy…
The uranium sector moved sharply higher this week, and CCO was part of the rally. But among its closest peers, Cameco was the quieter name. NXE gained 3.7% over the past week and DML added 5.3%. ISO and URE both…
CMS Energy filed its third-quarter results on Wednesday, and the conversation has shifted almost immediately from what shorts were doing ahead of the print to what the analyst community thinks of it after. Wells Fargo…
C.H. Robinson Worldwide reports Q3 results today, October 28, with short interest at its highest level in six weeks and analysts having cut targets sharply in the run-up to the print. Short sellers have been rebuilding…
Brown & Brown has just delivered its Q3 results, and the market's verdict is blunt: the stock fell 5% on the day to $67.55, unwinding a chunk of the 16% monthly rally that had built such bullish expectations into the…
EAT went into its October 28 earnings release with short sellers exiting, not adding, a meaningful shift from the rebuild documented just a week earlier. Short interest fell to 11% of the free float by October 27, down…
Boston Scientific reported third-quarter results today, October 28, with the stock at $45.06, still roughly 7% below the $48.33 price at which CEO Michael Mahoney bought $9 million of shares in a single discretionary…
BXP has just released its Q3 results today, and the data heading into the print told a story of two camps: short sellers adding conviction while options traders leaned the other way. Short interest built steadily…
BA has had a brutal week, falling 11.7% to $168.18, the kind of move that forces a reassessment of where the recovery story actually stands. The Q3 earnings report landed on October 27, and the market's verdict was…
Automatic Data Processing is the quietest stock in a noisy peer group this week, flat on the week while the closest comparables sold off sharply, and that relative calm is backed by some of the loosest short…
AAPL reports fiscal fourth-quarter results tomorrow, October 29, trading at $347.10 against a Street mean target of $332.39, a premium that has held despite two downgrades eight days ago and shows no sign of closing…
Amphenol reported Q3 results on October 28, and the market's reaction has shifted the story considerably since the pre-earnings note published three days ago. The stock jumped 3.9% on the day to $78.21, recovering…
American Electric Power has seen its short position shrink over the past week, even as the stock climbed to its best levels in a month, a combination that left bears caught on the wrong side of a 10% October…
AMZN reports Q3 results on Thursday after the close, with the stock at $253.10, down 3.6% over the past week and still roughly 7% below the all-time high set after Q2's blowout numbers. The key tension is not…
AMD closed Tuesday at $560.26, up 5.5% on the day and 4.8% on the week, a sharp reversal from the multi-week drawdown that had taken it from above $600 to a low around $516 just days ago. The rebound matters because it…
Short sellers added to positions in Abbott Laboratories at an unusual pace this week, even as the stock held broadly flat and the borrow market remained among the easiest in the sector. The short interest build is the…
